IntelGenx Technologies Corp.
IGX
Rangering i aksjer
#28118
IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise... IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise focused on the creation and manufacturing of advanced oral thin film products. The company's diverse product pipeline encompasses various oral film formulations designed to address a wide spectrum of medical conditions. These include INT0008/2008, a Rizatriptan film for migraine management; INT0046/2018 for adult applications; INT0007/2006, an oral film targeting erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, intended for opioid addiction treatment; INT0010/2006, addressing neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, formulated for schizophrenia or bipolar I disorder; and INT0048/2020, developed for veterinary health. Additionally, IntelGenx is actively developing other candidates identified as INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established strategic partnerships, including a comprehensive licensing, development, and supply agreement with Tilray, Inc., alongside a development pact with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.
Aksjekurs
$0.17446996
Sist synkronisert: 2024-06-11
Markedsverdi
$26.97M
Endring (1 dag)
-0.57%
Endring (1 år)
2.63%
Land
CA
Handel IntelGenx Technologies Corp. (IGX)
Kategori
Healthcare
Inntekter for IntelGenx Technologies Corp. (IGX)
Inntekter i Mar 2024 TTM: $1.05M
Ifølge de nyeste økonomiske rapportene til IntelGenx Technologies Corp. er selskapets nåværende inntekter (TTM) $1.05M. I 2022 hadde selskapet inntekter på $950.00K en nedgang sammenlignet med inntektene i 2021, som var $1.54M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for IntelGenx Technologies Corp. fra 2003 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $1.05M | 1.15% |
| 2023 | $1.04M | 9.37% |
| 2022 | $950.00K | -38.11% |
| 2021 | $1.54M | -0.58% |
| 2020 | $1.54M | 108.09% |
| 2019 | $742.00K | -59.32% |
| 2018 | $1.82M | -64.89% |
| 2017 | $5.20M | -0.48% |
| 2016 | $5.22M | 2.45% |
| 2015 | $5.10M | 207.11% |
| 2014 | $1.66M | 75.00% |
| 2013 | $948.00K | -21.52% |
| 2012 | $1.21M | 174.55% |
| 2011 | $440.00K | -67.09% |
| 2010 | $1.34M | 4.56% |
| 2009 | $1.28M | 30.93% |
| 2008 | $976.61K | 16.90% |
| 2007 | $835.42K | 214.18% |
| 2006 | $265.90K | 0.00% |
| 2005 | 0.00 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $12.62B | 1,201,070.31% |
US
|
|
| $2.23B | 211,888.58% |
US
|
|
| $15.74B | 1,497,933.03% |
AU
|
|
| - | - |
CH
|
|
| $6.02B | 572,810.31% |
NL
|
